Sublicense Fee. [ ] on all consideration (other than royalties under Section 1) received by the Company or an affiliate as a result of the grant of a Sublicense, or an option to Sublicense (such as upfront payments, milestones payments), provided, such consideration shall not include payment to fund research and development costs of the Company.
Appears in 3 contracts
Samples: Scopus BioPharma Inc., Scopus BioPharma Inc., Scopus Biopharma Inc.
Sublicense Fee. [ ] ]on all consideration (other than royalties under Section 1) received by the Company or an affiliate as a result of the grant of a Sublicense, or an option to Sublicense (such as upfront payments, milestones payments), provided, such consideration shall not include payment to fund research and development costs of the Company.
Appears in 2 contracts
Samples: Scopus BioPharma Inc., Scopus Biopharma Inc.